Sort
48,018 grants matching “immunotherapy”
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,668,869Mark Connors · Niaid Extramural Activities · Z01 · FY2007 · AI
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.
$1,668,143Michelle S Bradbury · Sloan-Kettering Inst Can Research · U54 · FY2015 · CA
Comprehensive dissection of the CLL genome & phenome to improve patient outcomes
$1,667,862Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Immunologic control of HIV-1 through combination bNAbs and biologics.
$1,667,616Marina Caskey · Rockefeller University · U01 · FY2022 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,667,113New York University School Of Medicine · U01 · FY2003 · AI
Protein Expression
$1,666,739Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2017 · ES
A system approach to targeting innate immunity in AD
$1,665,226Todd E. Golde · University Of Florida · U01 · FY2014 · AG
MSKCC -Cornell Center for Translation of Cancer Nanomedicines.
$1,664,540Michelle S Bradbury · Sloan-Kettering Inst Can Research · U54 · FY2019 · CA
Immunotherapy of low grade lymphoid malignancies
$1,663,921Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
TIL Rosenberg Modular Processing Facility (T30 building)
$1,663,555Jean-Patrice Khoshbin · Office Of The Director, Nci · ZII · FY2024 · CA
ANCA Glomerulonephritis: From Molecules to Man
$1,663,528Ronald J Falk · Univ Of North Carolina Chapel Hill · P01 · FY2016 · DK
SOFT TISSUE SARCOMA PROGRAM PROJECT
$1,662,853Sloan-Kettering Institute For Cancer Res · P01 · FY2001 · CA
Lyme Disease: B cell epitope discovery and mechanisms of antibody protection
$1,660,786Nicholas J Mantis · Nysdoh/Health Research, Inc. · N01 · FY2019 · AI
ANCA Glomerulonephritis: From Molecules to Man
$1,659,852Ronald J Falk · Univ Of North Carolina Chapel Hill · P01 · FY2015 · DK
Thermo Scientific Orbitrap Astral Mass Spectrometer
$1,658,828Lauren Elizabeth Ball · Medical University Of South Carolina · S10 · FY2025 · OD
Yale SPORE in Skin Cancer
$1,657,668Marcus W Bosenberg · Yale University · P50 · FY2024 · CA
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
$1,657,600Luis J. Montaner · Wistar Institute · R01 · FY2020 · DA
Project 1
$1,657,050Carl H. June · University Of Pennsylvania · U54 · FY2019 · CA
SPORE in Prostate Cancer
$1,656,783Sarki A. Abdulkadir · Northwestern University At Chicago · P50 · FY2021 · CA
Enhancing T Cell Therapy of Cancer
$1,656,055Baylor College Of Medicine · P01 · FY2004 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$1,655,127New York University School Of Medicine · U01 · FY2002 · AI
Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas
$1,654,855E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2025 · CA
Coordinating center for the NCI small cell lung cancer research consortium
$1,654,600Charles M Rudin · Sloan-Kettering Inst Can Research · U24 · FY2022 · CA
Effects of mu-opiate receptor engagement on microbial translocation and residual immune activation in HIV-infected, ART suppressed opioid use disorder patents initiating medication-assisted treatment
$1,652,477Luis J. Montaner · Wistar Institute · R01 · FY2022 · DA
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
$1,651,535Darell D Bigner · Duke University · P01 · FY2012 · CA